Benzinga | Aug 12, 2020 04:24PM EDT

Biocept Q2 EPS $(0.05) Up From $(0.38) YoY, Sales $917.47K Miss $1.45M Estimate

Biocept (NASDAQ:BIOC) reported quarterly losses of $(0.05) per share. This is a 86.84 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $917.47 thousand which missed the analyst consensus estimate of $1.45 million by 36.73 percent. This is a 22.97 percent decrease over sales of $1.19 million the same period last year.